Welcome to our dedicated page for Qscreen AI news (Ticker: PMEDF), a resource for investors and traders seeking the latest updates and insights on Qscreen AI stock.
QScreen AI Inc. develops artificial-intelligence health screening technology for clinical, correctional, occupational, and institutional settings. Company news centers on the QAI Platform, which combines physiological signals from a standard camera, passive voice analysis, and structured clinical intake workflows to support real-time screening and documented intake outputs.
Recurring updates cover platform integration, internal validation work, patent activity, commercialization efforts in North American institutional and workforce markets, strategic advisory and contractor relationships, and financing actions tied to deployment and working capital. The company also reports on clinical instruments used within its intake workflows, including CIWA-Ar, COWS, and C-SSRS.
Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) announces the deployment of its COVID-19 and impairment screening technology at Indian Oil Corporation Ltd, a Fortune 500 company. The deployment will begin in 3-4 weeks, marking Predictmedix's entry into the Oil & Gas sector. Additionally, the company appointed Kiran Kumari to its advisory board for business development in the Asia Pacific region. Predictmedix also filed a US patent application for a healthcare provider reward management system, further enhancing its telehealth capabilities. The company aims to address health safety across workplaces.